Cell Point reports revenue growth in FY26
Cell Point (India) Limited reported a net profit of ₹6.35 lakh for FY26, with revenue rising to ₹36,793.36 lakh. The Board approved the audited results and appointed M/s Sankaran and Krishnan as internal auditors for FY27.
*this image is generated using AI for illustrative purposes only.
Cell Point (India) Limited reported a net profit of ₹6.35 lakh for the year ended March 31, 2026, compared to ₹226.15 lakh in the previous year. Revenue from operations for the year increased to ₹36,793.36 lakh from ₹32,470.58 lakh in FY25. The company's Board of Directors approved the audited financial results for the half year and year ended March 31, 2026 during a meeting held on May 27, 2026.
The statutory auditors, M/s Rao and Kumar, issued an unmodified opinion on the standalone financial results. The Board also approved the appointment of M/s Sankaran and Krishnan, Chartered Accountants, as the internal auditor for the financial year 2026-27. Additionally, the Board considered and approved related party transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance
For the year ended March 31, 2026, the company reported a total revenue of ₹36,851.73 lakh. Total expenses for the period stood at ₹36,757.84 lakh. The profit before tax for the year was ₹93.89 lakh, down from ₹281.41 lakh in the previous year. The basic earnings per share (EPS) for the year was ₹0.034, compared to ₹1.210 in the prior year.
The half year ended March 31, 2026, recorded a net loss of ₹12.73 lakh. Revenue from operations for the half year was ₹19,098.82 lakh, while total expenses were ₹19,061.11 lakh.
Key Financial Metrics
| Metric | Year Ended Mar 31, 2026 (₹ in Lakhs) | Year Ended Mar 31, 2025 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations | 36,793.36 | 32,470.58 |
| Total Revenue | 36,851.73 | 32,625.86 |
| Total Expenses | 36,757.84 | 32,579.08 |
| Profit Before Tax | 93.89 | 281.41 |
| Net Profit | 6.35 | 226.15 |
| Basic EPS (₹) | 0.034 | 1.210 |
Assets and Liabilities
The company's total assets stood at ₹16,910.50 lakh as of March 31, 2026, up from ₹13,815.82 lakh in the previous year. Total shareholders' funds increased marginally to ₹7,431.74 lakh from ₹7,425.39 lakh. Non-current liabilities rose significantly to ₹3,180.45 lakh, primarily due to an increase in long-term borrowings which stood at ₹3,114.95 lakh.
Current liabilities were recorded at ₹6,298.31 lakh. The company's cash and cash equivalents decreased to ₹592.68 lakh from ₹644.26 lakh at the end of the previous year.
Historical Stock Returns for Cell Point
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -9.02% | +2.15% | -2.35% | -8.77% | -6.98% | -73.10% |
What strategies will the company implement to restore profit margins given the significant decline in net profit despite revenue growth?
How does the company plan to manage the increased long-term borrowings and potential interest obligations in the upcoming fiscal year?
Will the recent appointment of a new internal auditor lead to changes in cost control measures or operational efficiency?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
